Background: Ubiquitination-related transcriptional programs may help characterize epithelial heterogeneity in endometrial carcinoma (EC). We aimed to identify candidates associated with these programs and epithelial plasticity. Methods: We integrated a 43,613-cell atlas from five endometrioid EC samples and two normal endometrial samples with bulk transcriptomic, genetic-association and protein-expression data. Five scoring methods defined a consensus expression score, with HIGH and LOW quartiles defined within the Epithelial + EMT_like lineage. Differential expression and high-dimensional weighted gene co-expression network analysis (hdWGCNA) identified candidates for exploratory Mendelian randomization (MR) and survival-based prioritization among 541 patients from The Cancer Genome Atlas Uterine Corpus Endometrial Carcinoma (TCGA-UCEC) cohort. Repeated nested cross-validation and cross-model feature support were used to evaluate internal performance and candidate stability. Pseudobulk, independently curated ubiquitin–proteasome system (UPS) gene sets and scSurv input masking provided sensitivity analyses. Results: The lineage-restricted screen identified 444 candidates, including 412 detectable in TCGA. GeneCards and curated Reactome and KEGG UCell scores were positively correlated (ρ = 0.519 and 0.579). YWHAB ranked fourth among 412 genes in the top-10% workflow analysis and fifth in the top-20% sensitivity analysis. Among the 12 nominal MR-associated genes, it had the highest machine-learning priority. Its single-nucleotide polymorphism (SNP) MR estimate was nominal (odds ratio (OR) = 1.732, p = 0.0488) and did not survive multiple-testing correction. Higher bulk YWHAB expression was associated with poorer overall survival (HR = 2.188, 95% CI 1.559–3.072). Western blotting showed higher YWHAB protein expression in EC than controls (nine versus nine tissues, p = 0.0027), consistent with descriptive Human Protein Atlas (HPA) staining. Single-cell analyses associated YWHAB with RNA processing, proteostasis-related expression and epithelial-state heterogeneity. Conclusions: Lineage-restricted discovery and cross-model prioritization identify YWHAB as an exploratory candidate associated with ubiquitination-related transcriptional programs in EC. Protein-expression evidence supports its further investigation, while causal function and clinical prognostic utility require independent validation.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: